Publications:

Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.

Plos One

Ono, Ryoichi R; Masuya, Masahiro M; Inoue, Naokazu N; Shinmei, Makoto M; Ishii, Satomi S; Maegawa, Yuri Y; Maharjan, Bishnu Devi BD; Katayama, Naoyuki N; Nosaka, Tetsuya T

Publication Date: 2021

Variant appearance in text: TET2: E47F

PubMed Link: 33705482

Variant Present in the following documents:

• Main text

View BVdb publication page

Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia.

Communications Biology

Guan, Yihong Y; Greenberg, Edward F EF; Hasipek, Metis M; Chen, Shi S; Liu, Xiaochen X; Kerr, Cassandra M CM; Gackowski, Daniel D; Zarakowska, Ewelina E; Radivoyevitch, Tomas T; Gu, Xiaorong X; Willard, Belinda B; Visconte, Valeria V; Makishima, Hideki H; Nazha, Aziz A; Mukherji, Mridul M; Sekeres, Mikkael A MA; Saunthararajah, Yogen Y; Oliński, Ryszard R; Xu, Mingjiang M; Maciejewski, Jaroslaw P JP; Jha, Babal K BK

Publication Date: 2020-09-07

Variant appearance in text: TET2: E47F

PubMed Link: 32895473

Variant Present in the following documents:

• Main text

View BVdb publication page